Ryan Michael Winder, ARNP, FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 615 A Ave Se, Mount Vernon, IA 52314 Phone: 319-721-5142 |
Ms. Stephanie Michele Friess, ANP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 713 1st Ave Nw, Mount Vernon, IA 52314 Phone: 907-350-7228 |
Dr. Liv Kelley-sellnau, ARNP FNP-BC PMHNP-BC Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 120 Ink Rd Nw, Mount Vernon, IA 52314 Phone: 319-431-5538 |
News Archive
DelMar Pharmaceuticals, Inc., announced today that the FDA Office of Orphan Products Development (OOPD) has granted orphan drug designation for its lead product candidate, VAL-083, in the treatment of medulloblastoma.
According to scientific estimations, humans are exposed to at least 10,000 to 100,000 environmental and exogenous compounds in an individual lifetime, which are mainly absorbed through our dietary.
An investigation undertaken by Novozymes Biopharma DK has shown that when the corticosteroid dexamethasone is formulated in a cross-linked Hyaluronic acid (HA) hydrogel, the drug's in vitro release time increases from under 10 minutes to approximately 15 hours. In addition, the in vivo half-life of dexamethasone is shown to plateau with stable dexamethasone concentration up to four hours after injection.
A national survey of acute and critical care nurses finds that measures to reduce unnecessary testing and treatments are increasingly being integrated into clinical practice, even though most respondents are not aware of the campaign behind the specific recommendations.
› Verified 7 days ago